Concepedia

Douglas Girgenti

DG

11

Publications

465

Citations

11

H-Index

2011

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (Australia)

Cincinnati Children's Hospital Medical Center

The University of Adelaide

Women's and Children's Hospital

Douglas Girgenti is an author at Pfizer (United States) specializing in medicine, infection control, and host-pathogen interactions.

Top concepts

Publications per year

2011–2018

11

Publications

11

A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure

Julio C. Hawkins, Srinivas Kodali, Yury V. Matsuka et al. · Clinical and Vaccine Immunology · 2012 · 63 citations · Full text

, , +15

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

Robert W. Frenck, C. Buddy Creech, Eric Sheldon et al. · Vaccine · 2016 · 62 citations · Full text

A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults

Michael D. Nissen, Helen Marshall, Peter Richmond et al. · Vaccine · 2015 · 58 citations · Full text

Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

Otto G. Vanderkooi, David W. Scheifele, Douglas Girgenti et al. · The Pediatric Infectious Disease Journal · 2011 · 55 citations

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial

C. Buddy Creech, Robert W. Frenck, Eric Sheldon et al. · Vaccine · 2016 · 53 citations · Full text

Rows per page

1–5 of 11